Revisiting the culprit lesion in nonQ-wave myocardial infarction
Results from the VANQWISH trial angiographic core laboratory
Richard A. Kerensky, MD*,*,
Michael Wade, MS ,
Prakash Deedwania, MD ,
William E. Boden, MD ,
Carl J. Pepine, MD, MACC* Veterans Affairs NonQ-Wave Infarction Strategies in-Hospital (VANQWISH) Trial Investigators
* Malcom Randall Veterans Affairs Medical Center and the University of Florida College of Medicine, Division of Cardiovascular Medicine, Gainesville, Florida, USA
Veterans Affairs Medical Center and the State University of New York Health Science Center, Syracuse, New York, USA
Veterans Affairs Medical Center, Fresno, California, USA
Division of Cardiology at Hartford Hospital, Hartford, Connecticut, USA

View larger version (43K):
[in a new window]
|
Figure 1 Rates of revascularization with percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass grafting (CABG) in patients with no culprit lesion, one culprit lesion or multiple culprit lesions. Patients with one culprit lesion are divided into two groups: incomplete occlusion or acute total occlusion. *Single incomplete occlusion vs. no or multiple culprit lesions, p < 0.001; **Single incomplete occlusion vs. single acute occlusion, p = 0.128; ***Multiple culprit lesions vs. other groups, p = 0.010.
|
|
|